Ipamorelin + CJC-1295
cjc ipacjc/ipa
Classic GHRH + GHRP pairing. Comparison of paired GH-releasing peptides with protocol structure and tracking.
- Half-life
- Not established
- Out of system
- —
- Route
- Subcutaneous
- Level
- Intermediate
What Ipamorelin + CJC-1295 is used for
- Classic GHRH (CJC No-DAC) + GHRP (Ipamorelin) pairing
- Synergistic GH pulse for recovery, sleep, body composition
How it's typically used
Research range: 100 mcg of each subcutaneous, 1–3× daily.
What to watch for
- GH-side effects: water retention, tingling, glucose changes
- Effects fade with desensitization over months
- Avoid with cancer, diabetes, or pituitary issues
About Performance & GH
- What they are
- Growth-hormone secretagogues and related performance compounds. Rather than supplying GH, they push your pituitary to release more of its own in a pulse.
- How they're run
- Subcutaneous injection, most often at night on an empty stomach so the pulse lands with natural sleep-driven GH release.
- What to watch
- Water retention, tingling hands, and hunger swings are the common early signs. Raising GH raises IGF-1 — worth tracking on bloodwork, and a reason to avoid these with any cancer history.
Full guide
Ipamorelin and CJC-1295: A Practical Tracking Guide
Two growth-hormone-releasing peptides that are usually used together. How they differ, how protocols are structured, and what to track.
Other performance & gh
Peptid AI is an educational and self-tracking tool — not a medical service, and not a vendor. Nothing here is medical advice, a prescription, or an endorsement. Doses reflect what is commonly reported in research literature; they are not recommendations. Many compounds listed are experimental, not approved for human use, and/or controlled substances that are illegal to possess without a prescription in many countries. Always consult a qualified physician before starting, changing, or stopping any protocol.